期刊文献+

小肝癌螺旋CT门脉期最大强化率与病理及免疫组化的研究 被引量:5

Small Hepatocellular Carcinoma:Multiple linear Regression Analysis of Correlation of Peak Contrast Enhancement Ratio in Portal Phase on Multiphase Spiral CT with Histopathological and Immunohistochemical Findings
下载PDF
导出
摘要 目的:对小肝细胞肝癌(SHCC)的螺旋CT多期扫描肿瘤门脉期强化程度与组织分级、p53、p21、CD34、VEGF表达的相关性进行多因素分析,试图以螺旋CT多期扫描的影像学评价SHCC的生物学特性,为SHCC的治疗和预后判断提供新的依据。方法:手术病理证实SHCC30例,共33个癌结节,术前均进行螺旋CT多期扫描,其中男26例,女4例。术后肿瘤行大体病理及其HE染色、免疫组化染色分析。结果:门脉期最大强化率高的肿瘤,CD34和p53多为高表达,VEGF多为低表达。三者的标准回归系数分别为0.2809,0.6042和-0.2590,其中p53最大,即p53与癌灶门脉期最大强化率的关系最密切;CD34和VEGF与癌灶门脉期最大强化率的相关性类似,但作用方向相反。结论:螺旋CT多期增强扫描可比较全面观察肿瘤,反映SHCC的生物学特性,且无创、快捷、可重复运用。根据SHCC的螺旋CT征象,可间接评价其相关基因的表达,为SHCC的治疗和预后判断提供新的有价值的依据。 Objective:To study the relationship among peak contrast enhancement ratio in portal phase on multiphase spiral CT and grade of cell differentiation,p53,p21,VEGF,CD34 expressions of small hepatocellular carcinoma (SHCC) by using multiple linear regression analysis,to explore the potency of SCT for evaluating biological features of SHCC and to search for new approaches to SHCC treatment and predicting prognosis.Methods:Multiphase spiral CT scans were performed in 30 patients with 33 lesions of SHCC (≤3.0cm in diameter) confirmed histopathologically.Of these patients 26 were male and 4 were female,aged from 34 to 70 (mean 50.1 years old).Immunohistochemical and HE staining were performed in surgical samples of all patients with SHCC.All samples' size was measured and the number of masses in each patient was counted.Results:SHCC with high pCER in portal vein phase always had higher level of CD34 and p53 expression,and lower level of VEGF expression.P53 expression was the most important factor contributing to pCER of SHCC in portal vein phase (R=0.6042),and then CD34 (R=0.2809) and VEGF (R=0.2590).Conclusion:Multiphase spiral CT is an method to comprehensively assess biological behaviors of SHCC in a noninvasive,quick and repeatable way.Genes expression of SHCC can be assessed indirectly,and valuable approaches to SHCC treatment and predicting prognosis can be achieved by SCT features of SHCC.
出处 《放射学实践》 2005年第7期587-591,共5页 Radiologic Practice
基金 广西自然科学基金(0007046)
关键词 肝肿瘤 体层摄影术 X线计算机 病理学 基因 p53 p21 血管内皮生长因子 抗原 CD34 Liver neoplasms Tomography,X-ray computed Pathology Gene,p53,p21 Vascular endotheliel growth factor (VEGF) Antigens,CD34
  • 相关文献

参考文献31

  • 1Gras Kraupp B,Ruttay-Nedecky B,Mlauer L,et al.Inherent Increase of Apoptosis in Liver Tumors:Implication for Carcinogenosis and Tumor Regression[J].Hepatology,1997,25(4):906.
  • 2Heinze T,Jonas S,Karsten A,et al.Determination of the Oncogene p53 and CerbB2 in Tumor Cytosoles of Advanced Hepatocellular Carcinoma (HCC) and Correlation to Survival Time[J].Anticancer Res,1999,19(5):2501-2503.
  • 3孙惠川,汤钊猷.肿瘤血管研究及其在肝癌领域的进展[J].中国癌症杂志,2000,10(6):562-565. 被引量:8
  • 4Weidner N.Tumoural Vascularity as a Prognostic Factor in Cancer Patients:the Evidence Continues to Grow[J].J Pathol,1998,184(2):119-122.
  • 5Zagzag D,Goldenberg M,Brem S.Angiogenesis and Blood-Brain Barrier Breakdown Modulate CT Contrast Enhancement:an Experimental Study in a Rabbit Brain-Tumor Model[J].AJR,1989,153(1):141-146.
  • 6Tateishi U,Nishihara H,Tsukamoto E,et al.Lung Tumors Evaluated with FDG-PET and Dynamic CT:the Relationship between Vascular Density and Glucose Metabolism[J].J Comput Assist Tomogr,2002,26(2):185-190.
  • 7Pathak AP,Schmainda KM,Ward BD,et al.MR-Derived Cerebral Blood Volume Maps:Issues Regarding Histological Validation and Assessment of Tumor Angiogenesis[J].Magn Reson Med,2001,46(4):735-747.
  • 8Brasch R,Turetschek K.MRI Characterization of Tumors and Grading Angiogenesis Using Macromolecular Contrast Media:Status Report[J].Eur J Radiol,2000,34(3):148-155.
  • 9Kwak BK,Shim HJ,Park ES,et al.Hepatocellular Carcinoma:Correlation between Vascular Endothelial Growth Factor Level and Degree of Enhancement by Multiphase Contrast-Enhanced Computed Tomography[J].Invest Radiol,2001,36(8):487-492.
  • 10许乙凯,程天明,刘杏元,刘晓霞.肝癌CT边缘形态与微血管密度关系的初步研究[J].放射学实践,2000,15(1):30-32. 被引量:24

二级参考文献39

  • 1贺斌,汤钊猷,刘康达,周铬.应用p53基因型探索肝细胞肝癌起源的研究[J].中华肿瘤杂志,1996,18(5):335-338. 被引量:4
  • 2沈冰奇,郑可国,许达生,薛玲,赖英荣.肝细胞癌边缘部的CT与病理对照研究[J].中华放射学杂志,1996,30(12):815-819. 被引量:17
  • 3朱焕章,张新立,陈意生.突变型p53蛋白在二乙基亚硝胺诱发大鼠肝癌前病变中的表达[J].中华肿瘤杂志,1997,19(1):22-24. 被引量:15
  • 4[1]EI-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver[J]. Hepatology, 1998,27:1554 - 1562.
  • 5[2]Sun HC, Tang ZY, Li XM, et al. Microvessel density of hepatocellular carcinoma: its relationship with prognosis[J]. J Cancer Res Clin Oncol, 1999,125: 419 - 426.
  • 6[3]Kimura H, Nakajima T, Kagawa K, et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry [J]. Liver,1998,18:14- 19.
  • 7[4]Ker CG, Chen HY,Juan CC, et al. Role of angiogenesis in hepatitis and hepatocellular carcinoma [J]. Hepatogastroenterology, 1999, 46: 646-650.
  • 8[5]Hawighorst H, Knapstein PG, Weikel W, et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement [J]. Cancer Res, 1997,57:4777 - 4786.
  • 9[6]Takahashi Y, Bucana CD, Cleary KR, et al. P53, vessel count and vascular endothelial growth factor expression in human colon cancer[J]. Int J Cancer, 1998,79:34 - 38.
  • 10[7]Tanigawa N, Lu C, Mitsui T, et al. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance[J].Hepatology, 1997,26:1216 - 1223.

共引文献108

同被引文献48

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部